2023-2024 Regular Session • North Dakota Legislature
SB2384
Legislative Summary
A BILL for an Act to provide for a legislative management study relating to vaccines for respiratory syncytial virus and vaccines developed using messenger ribonucleic acid technology.
Bill History
1/23/2023
Introduced, first reading, referred to Human Services
Senate
2/7/2023
Committee Hearing 09:30
Senate
2/8/2023
Committee Hearing 03:44
Senate
2/9/2023
Reported back, do not pass, placed on calendar 6 0 0
Senate
2/9/2023
Amendment proposed on floor
Senate
2/9/2023
Amendment adopted
Senate
2/9/2023
Second reading, passed, yeas 25 nays 22
Senate
2/10/2023
Received from Senate
House of Representatives
2/17/2023
Introduced, first reading, referred to Human Services
House of Representatives
3/15/2023
Committee Hearing 02:30
House of Representatives
4/3/2023
Reported back, do not pass, placed on calendar 7 6 1
House of Representatives
4/4/2023
Second reading, failed to pass, yeas 38 nays 53
House of Representatives
Roll Call Votes
House Second reading
4/4/2023
38
Yea
53
Nay
0
Not Voting
3
Absent
Result: FAILED
Senate Second reading
2/9/2023
25
Yea
22
Nay
0
Not Voting
0
Absent
Result: PASSED
Status Information
Current Status
Engrossed(2/10/2023)
Chamber
House of Representatives
Sine DiePrior Session
Sponsors
Republican: 4
Primary Sponsor
Jeffery Magrum
Republican